Study the level of some serum lipid profile parameters in patients with an ischemic heart disease
Article Sidebar
Main Article Content
Abstract
Ischemic Heart Disease (IHD) is a dangerous because it restricts the blood flow to the arteries which lead to a atherosclerosis.
The study aimed to detect the effect of serum lipids on the IHD occurrence for( 59)patients in Kirkuk General hospital form the period of 1st September /2014 till the end of December 2014.
The serum lipids including Triglycerides(TG),Cholesterol and High density lipoprotein (HDL) were estimate by using enzymatic colorimetric method.
The study result indicated that there is a significant relationship between cholesterol and TG level and disease occurrence among the age group (60-69) and (70-79) years of age and there was a statistically relationship between these biochemical variable (cholesterol, HDL and TG in IHD occurrence in female.
The study concluded that (TG) level in blood is one of the important risk factor in IHD development
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Tikrit Journal of Pure Science is licensed under the Creative Commons Attribution 4.0 International License, which allows users to copy, create extracts, abstracts, and new works from the article, alter and revise the article, and make commercial use of the article (including reuse and/or resale of the article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made, and the licensor is not represented as endorsing the use made of the work. The authors hold the copyright for their published work on the Tikrit J. Pure Sci. website, while Tikrit J. Pure Sci. is responsible for appreciate citation of their work, which is released under CC-BY-4.0, enabling the unrestricted use, distribution, and reproduction of an article in any medium, provided that the original work is properly cited.
References
1- Global health risks; (2009); Mortality and burden of disease attributable to selected major risks: Geneva, World Health Organization. 2- Kotseva, K.A (2009) :Cardiovascular prevention guidelines in daily practice a comparison of EUROASPIRE I,II, and III surveys in eight European countries Lancet ;373(9667):929-40. 3- Yusuf, S,; Hawken, S and Ounpuu, S (2004) " Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries", case- control study. Lancet. 2004; 364 (9438): 937-952. 4-Krauss, RM,; Eckel, RH, ;Howard, B, ;Appel. LJ,; Daniels, SR, and Deckelbaum RJ, et al.(2000); AHA Dietary guidelines: Revision : A statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation ;102(18):2284-2299.
5-Mendle, S,; et al;(2005); WHO study on prevention of Recurrences of Myocardial Infarction and StrokE (WHO-PREMISE). Bulletin of the World Health Organization ;83(11):820-9. 6- Cardiovascular Disease Risk in Immigrants; (2011); What Is the Evidence and Where Are the Gaps?Asia Pac J Public Health ; 23 (6): 882-895. 7- CDC. Million Hearts; (2011);"strategies to reduce the prevalence of leading cardiovascular disease risk factors". United states ;60(36):1248-51. 8-Lichtenstein, AH,; Deckelbaum, RJ.; (2001); AHA Science Advisory. Stanol/sterol ester - containing foods and blood cholesterol levels. A statement for healthcare professionals from the Nutrition Committee of the Council on Nutrition, Physical Activity, and Metabolism of the American Heart Association. Circulation.; 103(8):1177-1179. 9- Haase , C.L,; Tybjærg-Hansen, A,; Qayyum. A.A.; Schou, J,; Nordestgaard, B.G,; and Frikke-Schmidt, R.; (2012); LCAT, HDL cholesterol and ischemic cardiovascular disease: a Mendelian randomization study of HDL cholesterol in 54,500 individuals. J Clin Endocrinol Metab. ;97:E248-E256. 10-Aiyer, A.N,; Kip, K.E.; Marroquim, O.C,; Mulukutla, S.R,; Edmundowicz, D, and Reis, S.E.; (2007); "Racial Differences In Coronary Artery Calcification Are Not Attributed To Differences In Lipoprotein Particle Sizes: The Heart Strategies Concentrating On Risk Evaluation"(Heart SCORE) Study. Am Heart J.;153: (328-334) .
11- Tietz, N. W. (1987). Fundamentals of clinical chemistry. 3rd ed W. B. Saunders company, USA.
12-Amir,Q: Stephan, D,; Fihn, MD, et al (2012); Management of Stable Ischemic Heart Disease ; For the Clinical Guideline committee of the American college of physicians;157:735-743.
13-Micochova, V,; (2013); Smoking and Nutrition; Journal of Nutritional Therapeutics; 213-217 14- Kotseva, K et al.; (2009); EUROASPIRE III: A survey on then lifestyle, risk factors and use of cardio protective drug therapies in coronary patients from 22 European countries. European journal of cardiovascular Prevention and Rehabilitation.; 16(2): 121-37. 15- Baxter, P.; Petch, M.;(2000) ‘Cardiovascular Disorders’ in Cox, R. Edwards, F. Palmer, K. (Eds.) ‘Fitness for Work Oxford University Press, Oxford. ; 3rd Edition: (349-70) . 16- Pirro, matleo,; Mauriege, pascale, (2002); Tcheruof, Andr, Cantin, berhard; "Diagnosis, and Gilles - R:Despres,Tean Pierre: plasma free fatty acid levels and the risk of IHD in men": prospective and the risk from the quebec Cvs study, Med - line, Atherosclerosis.; 160(2): (377-84). 17- Scherle - ce; Nasiff - A; Bejueria - RA; Perez - Neller - jecorine - Rodrijuez - Aj; (1998); lpid & "lipoprotein may increase in patient, suffer ischemic CVS".Rev-Neurol;27(l59): PP( 804-8) . 18- Helstrom, Hr-R,; (2001);cholesterol & imp "Relatively over emphasized risk factor for IHD". Med-Hypothesis-;57(5): ( 567-601) . 19- Janne, -D,; Koren - Movag,-N,; Graff, -E, Jooldbourt,-u; (2001);" blood lipid & first-ever ischemic stroke/transient ischemic attack in the
Benafierace - infarction prevention (BIP) Registry: High TGA constituent & indented risk factor". circulation; 104(24): pp (2928-7) .
20-Chapman, M.J,; Ginsberg, H.N.; Amarecno, P.; (2011); Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur Heart J. ;32:( 1345-1361) .
21- Miller, M,; Stone, N.J,; Ballantyne, C,; (2011); Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. ;123:(2292-2333) .